Hyperphosphatemia
📧 Sign up to get email alerts when something new happens for Hyperphosphatemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders [Phase 3]
Clinical trial update announcing a Phase 3 study of TS-172 for hyperphosphatemia in patients on hemodialysis, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: AP301 Efficacy and Safety in Chinese Dialysis Patients With Hyperphosphatemia [Phase 3]
Phase 3 trial of AP301 for hyperphosphatemia in Chinese dialysis patients has completed.
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis [Phase 3]
This update reports the completion of a Phase 3 study evaluating TS-172 for treating hyperphosphatemia in patients on hemodialysis.
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease [Phase 3]
Phase 3 trial update on ferric citrate for the prevention of renal failure in adults with advanced chronic kidney disease; trial has complet…
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: A Phase 2 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders [Phase 2]
Phase 2 trial of TS-172 for hyperphosphatemia in patients on hemodialysis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: A Phase 2 Dose-finding Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis [Phase 2]
Phase 2 dose-finding study of TS-172 in hyperphosphatemia patients on hemodialysis has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-02Clinical Trial Update: A Study to Evaluate Safety, Tolerability and Efficacy of AP306 At Fixed Doses in Patients with Hyperphosphatemia [Phase 2]
Phase 2 study evaluating AP306 at fixed doses for safety, tolerability, and efficacy in hyperphosphatemia associated with chronic kidney dis…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Single and Multiple Dosing Study in Hemodialysis Patients With Hyperphosphatemia in Japan [Phase 1]
Astellas-sponsored Phase 1 single- and multiple-dose study in Japanese patients with hyperphosphatemia undergoing hemodialysis (in the conte…
-
CLINICAL_TRIALS trial_result · 2024-10-22Clinical Trial Update: Post-Marketing Surveillance on Long-Term Drug Use of Kiklin (Bixalomer)® Capsules in Patients With Hyperphosphatemia Receiving Peritoneal Dialysis
Post-marketing surveillance study evaluating long-term safety and real-world use of bixalomer (Kiklin) capsules for hyperphosphatemia in pat…
-
CLINICAL_TRIALS trial_result · 2024-08-06Clinical Trial Update: Efficacy and Safety of Cholestyramine in the Management of Hyperphosphatemia in Adult Hemodialysis Patients [Phase 4]
Phase 4 clinical trial update evaluating cholestyramine for managing hyperphosphatemia in adults undergoing hemodialysis.
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: Explore the Effectors of The Transtheoretical Model on Nutritional Education in Patients on Hemodialysis [NA]
A completed trial evaluating the effect of applying the transtheoretical model on nutritional education for patients on hemodialysis with en…
-
CLINICAL_TRIALS trial_result · 2024-04-17Clinical Trial Update: Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis [Phase 3]
Phase 3 trial evaluating ferric citrate for treating hyperphosphatemia in patients with chronic kidney disease on hemodialysis has completed…
-
CLINICAL_TRIALS trial_result · 2024-03-07Clinical Trial Update: Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients [Phase 2]
Phase 2 clinical trial update for a phosphate binder combination (KHK7791) in hyperphosphatemia patients has completed.
-
CLINICAL_TRIALS trial_result · 2024-03-07Clinical Trial Update: A Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on HD [Phase 2]
Phase 2 clinical trial update for KHK7791 in hyperphosphatemia patients on hemodialysis has been completed.
-
CLINICAL_TRIALS trial_result · 2024-03-07Clinical Trial Update: Dose-finding Study of KHK7791 in Hyperphosphatemia Patients [Phase 2]
Phase 2 dose-finding study of KHK7791 for hyperphosphatemia has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-10Clinical Trial Update: A Study to Evaluate Safety and Efficacy of AP-306 in Hyperphosphatemia Patients [Phase 2]
Phase 2 trial evaluating safety and efficacy of AP-306 in patients with hyperphosphatemia due to chronic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol [Phase 4]
Phase 4 trial comparing calcitriol versus paricalcitol for management of mineral and bone disorders in hemodialysis, terminated with posted …
-
CLINICAL_TRIALS trial_result · 2023-08-02Clinical Trial Update: Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis [Phase 3]
Phase 3 trial update for KHK7791 in hyperphosphatemia patients on hemodialysis has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-29Clinical Trial Update: A Phase 3 Study of Tenapanor to Treat Hyperphosphatemia in ESRD Patients on Dialysis [Phase 3]
Phase 3 trial update for tenapanor in hyperphosphatemia among end-stage renal disease patients on dialysis; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2023-04-20Clinical Trial Update: A Study of Ferric Citrate to Improve Inflammation and Lipid Levels [Phase 4]
Phase 4 trial of ferric citrate in end-stage renal disease assesses inflammation and lipid levels; the study was terminated with results pos…
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: A Long-Term Study of Tenapanor Alone or in Combination With Sevelamer in Patients With CKD on Dialysis and HP [Phase 4]
Phase 4 trial evaluating long-term safety and efficacy of Tenapanor alone or with Sevelamer in dialysis patients with hyperphosphatemia and …
-
CLINICAL_TRIALS trial_result · 2023-03-06Clinical Trial Update: Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder Therapy [Phase 2, Phase 3]
A phase 2/3 clinical trial update on tenapanor as an adjunct to phosphate binder therapy for hyperphosphatemia has completed with results po…
-
CLINICAL_TRIALS trial_result · 2022-11-07Clinical Trial Update: Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis Participants [Phase 4]
Phase 4 trial update of Auryxia (ferric citrate) for in-center and home dialysis patients with hyperphosphatemia, anemia, or iron deficiency…
-
CLINICAL_TRIALS trial_result · 2022-10-18Clinical Trial Update: A Phase 2 Study to Evaluate the Safety and Efficacy of VS-505(AP301) to Treat Hyperphosphatemia in Hemodialysis Patients [Phase 2]
A Phase 2 clinical trial assessing safety and efficacy of VS-505(AP301) for treating hyperphosphatemia in hemodialysis patients has complete…
-
CLINICAL_TRIALS trial_result · 2022-01-13Clinical Trial Update: Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis Patients [Phase 4]
Clinical trial update on transitioning to ferric citrate for hyperphosphatemia in dialysis patients (Phase 4) with completed results.